Artificial Intelligence-Assisted Volumetric Brain Analysis Correlated with CSF Biomarkers in Alzheimer's Disease: A Pilot Study.
Source check: Source checked. Not independent scientific confirmation.
Finding: In 21 Indonesian patients with Alzheimer disease, AI-assisted MRI volumetry correlated regional brain volumes with CSF Aβ42 (including right entorhinal and posterior cingulate indexed volumes). This is a small cross-sectional association, not a diagnostic or causal result. The result is reported in the Diagnostics. It does not establish generalization beyond the reported setting or prospective real-world benefit.
Technology: uAI uses a deep-learning fully convolutional/ResNet-U-Net-based pipeline for brain segmentation and ROI volume extraction
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- uAI uses a deep-learning fully convolutional/ResNet-U-Net-based pipeline for brain segmentation and ROI volume extraction
- Test and result
- In 21 Indonesian patients with Alzheimer disease, AI-assisted MRI volumetry correlated regional brain volumes with CSF Aβ42 (including right entorhinal and posterior cingulate indexed volumes). This is a small cross-sectional association, not a diagnostic or causal result.
- Limitation / still unknown
- Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.mdpi.com/2075-4418/16/7/1050
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.